Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer
Status:
Completed
Trial end date:
2016-08-16
Target enrollment:
Participant gender:
Summary
- The primary objective is to determine the reduction in pain score by ketamine mouthwash
compared to placebo in head and neck cancer patients with refractory mucositis.
- The secondary objectives are to describe the duration of analgesia and adverse effects
associated with ketamine and placebo.